ArticleBMJ digital health & AI2026
COPE: Chain-of-Thought Prediction Engine for open-source large language model-based stroke outcome prediction from clinical notes.
Article in BMJ digital health & AI, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
11 authors.
Funding
Abstract
Objective: To develop and evaluate Chain-of-Thought Outcome Prediction Engine (COPE), a reasoning-enhanced large language model, for predicting 90-day functional outcomes after acute ischaemic stroke (AIS) from unstructured clinical notes. Methods: We included 464 patients with AIS who had discharge summaries and 90-day modified Rankin Scale (mRS) outcomes. COPE uses a two-step chain-of-thought (CoT) framework based on sequential open-source models (LLaMA-3-8B): the first generates intermediate clinical reasoning and the second outputs an mRS prediction. We compared COPE's performance with GPT-4.1, ClinicalBERT, a structured variable-based machine learning model (XGBoost) and a single-step large language model (LLM) without CoT. Performance was evaluated using mean absolute error (MAE), accuracy within ±1 mRS point (±1 ACC) and exact accuracy (ACC). Results: COPE achieved an MAE of 1.01 (95% CI 0.92 to 1.11), ±1 ACC of 74.4% (95% CI 69.9% to 78.8%) and ACC of 32.8% (95% CI 28.0% to 37.6%), comparable to GPT-4.1 (MAE, 1.00 (95% CI 0.90 to 1.09); ±1 ACC, 77.9% (95% CI 73.7% to 82.0%); ACC, 32.5% (95% CI 28.0% to 37.4%); p=0.72, 0.11 and 0.96). COPE demonstrated performance comparable to a strong structured-data baseline using XGBoost (MAE, 1.03 (95% CI 0.93 to 1.13); ±1 ACC, 73.9% (95% CI 69.4% to 78.5%); ACC, 33.3% (95% CI 28.5% to 38.2%); p=0.77, 0.87 and 0.89), and outperformed ClinicalBERT and the single-step LLM. Subgroup analyses showed consistent performance across sex and age, with higher error among older patients, those undergoing thrombectomy and those with longer summaries. Conclusions: COPE, a reasoning-enhanced framework using lightweight, open-source LLMs, achieved performance comparable to a proprietary model and to strong traditional baselines while operating without model retraining or manual feature engineering. It offers an accurate and privacy-preserving solution for outcome prediction from unstructured clinical text.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.